Allurion Technologies, INC. 8-K Filing
Ticker: ALURW · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1964979
Sentiment: neutral
Filing Stats: 998 words · 4 min read · ~3 pages · Grade level 11.5 · Accepted 2025-12-19 17:00:26
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share ALUR The New York Stock E
- $202.50 — mon stock, each at an exercise price of $202.50 per share of common stock ALUR WS T
Filing Documents
- alur-20251218.htm (8-K) — 124KB
- 0001193125-25-327032.txt ( ) — 268KB
- alur-20251218.xsd (EX-101.SCH) — 47KB
- alur-20251218_htm.xml (XML) — 7KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 18, 2025, Allurion Technologies, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") to consider and vote on the seven proposals set forth below, each of which is described in detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on November 24, 2025 (the "Proxy Statement"). The following actions were taken at such meeting: 1. The following nominees were re-elected to serve on the Company's Board of Directors (the "Board") until the Company's 2028 annual meeting of stockholders and until their respective successors are duly elected and qualified, based on the following votes: Nominee Votes For Withheld Broker Non-Votes Omar Ishrak, M.D. 3,633,612 109,159 1,508,891 Douglas Hudson 3,582,668 160,103 1,508,891 R. Jason Richey 3,563,130 179,641 1,508,891 2. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 5,191,443 22,708 37,511 0 3. The stockholders approved an amendment and restatement of the Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan (the "2023 Plan" and as amended and restated, the "Amended and Restated Plan") to (i) increase the number of shares of common stock, par value $0.0001 per share (the "common stock"), of the Company authorized for issuance thereunder (with a corresponding increase to the number of shares of common stock that may be issued in respect of incentive stock options), (ii) amend the definition of Fully-Diluted Shares Outstanding, (iii) lower the non-employee director compensation limit, and (iv) extend the term of the plan. The results of such vote were as follows: Votes For
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLURION TECHNOLOGIES, INC. Date: December 19, 2025 By: /s/ Brendan Gibbons Name: Title: Brendan Gibbons Chief Legal and People Officer